SCHEMBL2732070

SCHEMBL2732070

CCCCCCCCc1ccc(C(CC=O)[N+](=O)[O-])cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.45
HTR2A P28223 2/20 0.43
ESR1 P03372 2/20 0.41
ADRA2A P08913 2/20 0.41
ADORA3 P0DMS8 2/20 0.41
TACR2 P21452 2/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
SHBG P04278 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
HSPD1 P10809 1/20 0.41
ADRB3 P13945 1/20 0.41
HTR2C P28335 1/20 0.41
HSPE1 P61604 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16915553 0.85 KCNH2 (0.49) KCNH2HTR2AESR1ADRA2AADORA3
SCHEMBL902106 0.81 SPHK1 (0.48) KCNH2HTR2AESR1ADRA2AADORA3
SCHEMBL25356499 0.79 KCNH2 (0.39) KCNH2HTR2ALMNATHRATHRB
SCHEMBL16915555 0.76 THRB (0.48) KCNH2HTR2AESR1ADRA2AADORA3
SCHEMBL2723549 0.75 CYSLTR2 (0.42) KCNH2ESR1ADRA2AADORA3TACR2
SCHEMBL901587 0.73 CYSLTR2 (0.48) KCNH2HTR2AESR1ADRA2AADORA3
SCHEMBL28544650 0.73 CYSLTR2 (0.51) ALDH1A1CYSLTR2CYSLTR1THRATHRB
SCHEMBL28400146 0.71 ESR1 (0.59) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL26660483 0.71 ESR1 (0.59) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL11141986 0.71 ESR1 (0.59) HTR2AESR1ADRA2AADORA3TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3092222-A1 IMPROVED FINGOLIMOD PROCESS Emcure Pharmaceuticals Limited (IN) 2016-11-16 EP disclosed
WO-2015107548-A1 IMPROVED FINGOLIMOD PROCESS EMCURE PHARMACEUTICALS LIMITED (IN) 2015-07-23 WO disclosed
EP-2632889-A2 INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD Mapi Pharma Limited (IL) 2013-09-04 EP disclosed
WO-2012056458-A2 INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD MAPI PHARMA LTD. (IL) 2012-05-03 WO disclosed